WE USE
GENOMIC DATA
TO IMPROVE
THE LIVES
OF THOSE IN
HEALTH CRISIS

WE GET
LIFE-SAVING DRUGS
TO MARKET FASTER

Our patented, unsupervised system biology method uses
human genomic data to detect gene-environment interactions 
(GxE’s) using continuous variables, Genteract can predict what 
side effects an individual patient will have from drugs, find new
uses for existing drugs and match patients to the right drug.

70% OF DRUGS
FAIL TO GET TO MARKET

Drug discovery proof-of-concept uses case-control logic through
phase I, II and III clinical trials to identify genetic predictors of side-effects,
though most trials treat side effects as random events. These trials are 
time-consuming, negatively impacted by bad data, missing data and rely
heavily on participant reporting, which can be incomplete and inconsistent. 
This drives massive inefficiencies in clinical trials. It also leads to good drugs 
getting pulled because the cost of matching the right patient to the
right drug is costly or not possible.

GENTERACT MAKES
PRECISION MEDICINE
POSSIBLE

With Genteract precision, move life-saving drugs through clinical trials faster;
reduce the number of drugs that fail for safety concerns; rescue stalled drugs;
we can provide medical interventions faster for side-effect management;
as well as, find new applications and contraindications for existing drugs.

Will you join us?
• Fellowship

ABOUT US

The founding team includes a well-known reproductive geneticist, 
a scientific phenom, a highly sought-after, technologist 
and a passionate, female, medtech entrepreneur. 

OUR TEAM

Brody Holohan, PhD
CO-FOUNDER AND CSO

Developed the analytical
techniques for Genteract’s
gene-environment 
interaction detector

Joshua Sams
CO-FOUNDER AND CTO

Former TechCrunch50 CEO
Fintech, Consumer Apps, 
Genomics, Machine Learning

Alice Crisci
CO-FOUNDER AND ADVISOR

Specialty: HealthTech, 
Reproductive Genetics, 
Oncofertility, MedAnswers, 
Fertile Action

Santiago Munne, PhD
ADVISOR

Reproductive Geneticist
CooperSurgical, 
Phosphorus Genomics

Mark Holohan
ENTREPRENEUR

Business Development,
Revenue Acceleration

Sebastian Arcila
DATA TEAM

Renowned Expert in Large 
Distributed Systems. Systems 
Engineering, Mathematics, 
Algorithms, and Data Structures
Multiple winner of global 
ACM-ICPC challenges

Dr. Charles Sims
CO-FOUNDER AND FORMER, 
CEO CALIFORNIA CRYOBANK

Stem Cell, Cryopreservation 
and Genomics

Matthew Likens
FORMER CEO, ULTHERA

Biotech development, 
Medical devices

Dr. Jerry W. Shay
ADVISOR

The Southland Financial Corporation 
Distinguished Chair in Geriatrics
UT Southwestern Cell Biology, 
Telomeres, Aging and Cancer

Dr. Tim deMeyer
ADVISOR

University of Ghent
Computational Biology, 
Genomics

Dr. Ronen Tal-Botzer
ADVISOR

Artificial Intelligence Authority
Director of Genomics, 
Bar-Allan University

CONTACT US